Amalgamated Bank lowered its holdings in Colgate-Palmolive (NYSE:CL – Free Report) by 2.7% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 177,580 shares of the company’s stock after selling 4,991 shares during the period. Amalgamated Bank’s holdings in Colgate-Palmolive were worth $16,144,000 at the end of the most recent reporting period.
A number of other large investors have also recently modified their holdings of the business. Centricity Wealth Management LLC bought a new position in Colgate-Palmolive in the fourth quarter valued at $27,000. Union Bancaire Privee UBP SA bought a new stake in Colgate-Palmolive during the fourth quarter worth about $32,000. Hager Investment Management Services LLC bought a new position in shares of Colgate-Palmolive during the 4th quarter valued at about $36,000. Reston Wealth Management LLC purchased a new position in shares of Colgate-Palmolive during the 3rd quarter valued at about $42,000. Finally, Roxbury Financial LLC purchased a new position in shares of Colgate-Palmolive during the 4th quarter valued at about $43,000. Institutional investors own 80.41% of the company’s stock.
Colgate-Palmolive Stock Performance
Shares of CL opened at $92.36 on Wednesday. Colgate-Palmolive has a one year low of $85.32 and a one year high of $109.30. The company has a 50-day simple moving average of $88.86 and a two-hundred day simple moving average of $95.66. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58. The firm has a market capitalization of $74.95 billion, a PE ratio of 26.24, a price-to-earnings-growth ratio of 4.20 and a beta of 0.44.
Colgate-Palmolive Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Friday, February 14th. Investors of record on Tuesday, January 21st were paid a $0.50 dividend. The ex-dividend date of this dividend was Tuesday, January 21st. This represents a $2.00 annualized dividend and a dividend yield of 2.17%. Colgate-Palmolive’s payout ratio is 56.82%.
Analyst Ratings Changes
A number of research analysts have commented on CL shares. StockNews.com cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, January 9th. TD Cowen decreased their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, January 8th. UBS Group cut their price target on shares of Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating for the company in a research report on Monday, February 3rd. Wells Fargo & Company decreased their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a report on Tuesday, January 7th. Finally, JPMorgan Chase & Co. dropped their target price on Colgate-Palmolive from $103.00 to $97.00 and set an “overweight” rating for the company in a report on Monday, February 3rd. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat.com, Colgate-Palmolive has a consensus rating of “Hold” and an average price target of $101.16.
Read Our Latest Report on Colgate-Palmolive
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Articles
- Five stocks we like better than Colgate-Palmolive
- How to Invest in Blue Chip Stocks
- Nebius Slides Post-Earnings: A Long-Term Buy Opportunity?
- How to Evaluate a Stock Before Buying
- NVIDIA Stock: A Market Barometer in Tech’s Turbulent Times
- Investing in Travel Stocks Benefits
- Palantir Stock Nears Bear Market Territory – Why and What’s Next?
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.